PPARGC1A and Parkinson disease: Our results suggest that PK2 is an upstream positive regulator of PGC-1α, and thus PK2 receptor agonists could have therapeutic potential in restoring mitochondrial dysfunction and mitigating progressive dopaminergic neuron loss in PD.